I
Ioanna Xanthopoulou
Researcher at National and Kapodistrian University of Athens
Publications - 129
Citations - 3265
Ioanna Xanthopoulou is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Ticagrelor & Acute coronary syndrome. The author has an hindex of 26, co-authored 127 publications receiving 2723 citations. Previous affiliations of Ioanna Xanthopoulou include General University Hospital of Patras & University of Florence.
Papers
More filters
Journal ArticleDOI
Randomized Assessment of Ticagrelor Versus Prasugrel Antiplatelet Effects in Patients with ST-Segment–Elevation Myocardial Infarction
Dimitrios Alexopoulos,Ioanna Xanthopoulou,Vassilios Gkizas,George Kassimis,Konstantinos Theodoropoulos,George Makris,Nikolaos Koutsogiannis,Anastasia Damelou,Grigorios Tsigkas,Periklis Davlouros,George Hahalis +10 more
TL;DR: In patients with ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary intervention, both ticagrelor and prasugrel exhibit an initial delay in the onset of their antiplatelet action.
Journal ArticleDOI
Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study.
Dimitrios Alexopoulos,Anastasia Galati,Ioanna Xanthopoulou,Eleni Mavronasiou,George Kassimis,Konstantinos Theodoropoulos,George Makris,Anastasia Damelou,Grigorios Tsigkas,George Hahalis,Periklis Davlouros +10 more
TL;DR: In patients with ACS exhibiting HTPR while on clopidogrel 24 h post-PCI, ticagrelor produces a significantly higher platelet inhibition compared with prasugrel.
Journal ArticleDOI
Morphine Is Associated With a Delayed Activity of Oral Antiplatelet Agents in Patients With ST-Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Guido Parodi,Benedetta Bellandi,Ioanna Xanthopoulou,Capranzano P,Davide Capodanno,Renato Valenti,Katerina Stavrou,Angela Migliorini,David Antoniucci,Corrado Tamburino,Dimitrios Alexopoulos +10 more
TL;DR: In patients with ST-segment–elevation myocardial infarction, morphine use is associated with a delayed onset of action of the oral antiplatelet agents, and this association persisted after adjusting for the propensity to receive morphine and after excluding patients with vomit.
Journal ArticleDOI
Ticagrelor Crushed Tablets Administration in STEMI Patients: The MOJITO Study
Guido Parodi,Ioanna Xanthopoulou,Benedetta Bellandi,Vassilios Gkizas,Renato Valenti,Stavros Karanikas,Angela Migliorini,Christos Angelidis,Rosanna Abbate,Sotirios Patsilinakos,Giorgio Baldereschi,Rossella Marcucci,Gian Franco Gensini,David Antoniucci,Dimitrios Alexopoulos +14 more
TL;DR: In healthy volunteers, 300 mg clopidogrel administered crushed via a nasogastric tube results in faster and greater bioavailability of the drug compared with whole tablets administered orally.
Journal ArticleDOI
Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping
Dimitrios Alexopoulos,Gerasimos Dimitropoulos,Periklis Davlouros,Ioanna Xanthopoulou,George Kassimis,Eleana F. Stavrou,George Hahalis,Aglaia Athanassiadou +7 more
TL;DR: In patients with HTPR after PCI, prasugrel is more effective compared with high clopidogrel in reducing platelet reactivity, particularly in CYP2C19*2 carriers.